Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
WTI crude oil fell back below $82 per barrel, down 5.20% on the day.
2026-03-11
WTI crude oil fell back below $82 per barrel, down 5.20% on the day.
Back
Other News
2026-03-11
The CSI Convertible Bond Index closed up 0.47% in the morning session. Baichuan Convertible Bond 2, Lianrui Convertible Bond, Yuanxin Convertible Bond, Hebang Convertible Bond, and Jiayuan Convertible Bond led the gains, rising 12.12%, 9.98%, 8.71%,
The CSI Convertible Bond Index closed up 0.47% in the morning session. Baichuan Convertible Bond 2, Lianrui Convertible Bond, Yuanxin Convertible Bond, Hebang Convertible Bond, and Jiayuan Convertible Bond led the gains, rising 12.12%, 9.98%, 8.71%, 7.72%, and 7.29% respectively. Zhenhua Convertible Bond, Liyang Convertible Bond, Fenggong Convertible Bond, Yunji Convertible Bond, and Xinzhi Convertible Bond led the declines, falling 4.49%, 3.65%, 3.24%, 2.98%, and 2.96% respectively.
2026-03-11
Changshan Pharmaceutical stated on its interactive platform that the clinical trial of ibenatide for the indication of weight loss has not yet been completed, and there is no need to wait for the approval result of the indication of hypoglycemic cont
Changshan Pharmaceutical stated on its interactive platform that the clinical trial of ibenatide for the indication of weight loss has not yet been completed, and there is no need to wait for the approval result of the indication of hypoglycemic control before conducting the clinical trial of weight loss.
Chat with us
, powered by
LiveChat